SONOVA HOLDING (SONVY)
(Delayed Data from OTC)
$69.62 USD
+0.03 (0.04%)
Updated Aug 30, 2024 12:00 PM ET
3-Hold of 5 3
D Value C Growth C Momentum C VGM
SONOVA HOLDING (SONVY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$76.00 | $76.00 | $76.00 | 9.21% |
Price Target
Only one analyst offered a short-term price target of $76.00 for SONOVA HOLDING. This represents an increase of 9.21% from the last closing price of $69.59.
Analyst Price Targets (1 )
Broker Rating
SONOVA HOLDING currently has an average brokerage recommendation (ABR) of 2.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 2.43 a month ago based on seven recommendations.
Of the eight recommendations deriving the current ABR, three are Strong Buy, representing 37.5% of all recommendations. A month ago, Strong Buy represented 42.86%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/SONVY.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.50 | 2.50 | 2.43 | 2.43 | 2.43 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/28/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/13/2024 | UBS | Graham Doyle | Not Available | Hold |
5/21/2024 | Not Identified | Not Identified | Strong Buy | Hold |
12/1/2023 | Not Identified | Not Identified | Strong Sell | Strong Sell |
11/24/2023 | Exane BNP Paribas | Hugo Solvet | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.50 |
ABR (Last week) | 2.50 |
# of Recs in ABR | 8 |
Average Target Price | $76.00 |
LT Growth Rate | 8.10% |
Industry | Medical - Instruments |
Industry Rank by ABR | 77 of 253 |
Current Quarter EPS Est: | NA |